Cognitive screening in persons with chronic diseases in primary care: challenges and recommendations for practice

American Journal of Alzheimer's Disease and Other Dementias
Ponrathi AthilingamPhilip J Rogal

Abstract

An integrative literature review was performed to identify the challenges in current cognitive screening. The aim of the review was to serve as an evaluative resource to guide clinicians in the selection of the best available cognitive screening measures for early assessment of mild cognitive impairment (MCI) in people with chronic diseases. The review classified the available cognitive screening measures according to purpose, time to administer, and cognitive domains assessed as: 1) simple/ brief cognitive screening measures, 2) disease specific screening measures, 3) domain specific screening measures, 4) self-administered screening measures, and 5) technology-based screening measures. There is no single optimal cognitive measure for all patient populations and settings. Although disease specific cognitive screening measures are optimal, there is a lack of validated screening measures for many chronic diseases. Technology-based screening measure is a promising avenue for increasing the accessibility of cognitive screening. Future work should focus on translating available screening measures to mobile technology format to enhance the utility in busy primary care settings. Early cognitive screening in persons with chronic disea...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Mar 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·C PowerJ C McArthur
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·C KawasR Brookmeyer
Apr 1, 1997·Journal of Clinical and Experimental Neuropsychology·A M PaoloJ J Ryan
Mar 31, 1998·Archives of Neurology·P R SolomonW W Pendlebury
Feb 5, 1999·Neurology·H BuschkeR B Lipton
Jun 22, 2000·International Journal of Geriatric Psychiatry·K S HallH C Hendrie
Aug 3, 2000·Journal of Clinical and Experimental Neuropsychology·K Arbuthnott, J Frank
Dec 13, 2000·Neurology·B DuboisB Pillon
Mar 23, 2001·The Clinical Neuropsychologist·R D VanderploegJ A Mortimer
Mar 27, 2002·The International Journal of Neuroscience·D A AndersonP R Godding
Apr 12, 2002·Journal of the American Geriatrics Society·Henry BrodatyFelicia A Huppert
Sep 27, 2003·Journal of the American Geriatrics Society·Soo BorsonMary Ganguli
Jun 12, 2004·International Psychogeriatrics·Joella E StoreyHugh G Dickson
Aug 18, 2004·Journal of Molecular Neuroscience : MN·Tzvi DwolatzkyHoward Chertkow
Nov 24, 2004·International Psychogeriatrics·Anthony F Jorm
Mar 10, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·D William MolloyDavid L Lewis
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Jul 13, 2005·Archives of Neurology·Ronald C Petersen, John C Morris
Aug 27, 2005·BMC Geriatrics·Andrea CorsonelloUNKNOWN Gruppo Italiano di Farmacovigilanza nell'Anziano Investigators
Apr 25, 2006·Lancet·Serge GauthierUNKNOWN International Psychogeriatric Association Expert Conference on mild cognitive impairment
Jul 29, 2006·Diabetes Care·Medha MunshiKatie Weinger
Sep 16, 2006·International Journal of Geriatric Psychiatry·Eneida MioshiJohn R Hodges
Sep 20, 2006·Journal of the International Neuropsychological Society : JINS·Ralph H B BenedictBianca Weinstock-Guttman
Dec 21, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Breda CullenBrian A Lawlor
Jan 2, 2007·Journal of Pain and Symptom Management·Sheri R JacobsClaudio Anasetti
Feb 24, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Thomas P RossMorgan Pleasant
Apr 25, 2007·Journal of General Internal Medicine·Laurie L LaveryMary Ganguli
Sep 13, 2007·Applied Neuropsychology·Angela L JeffersonRobert A Stern
Apr 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Javier PagonabarragaAlexandre Gironell
Apr 19, 2008·The Quarterly Journal of Experimental Psychology : QJEP·Cesare Cornoldi, Irene C Mammarella
May 2, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·B J MilneT E Moffitt
Aug 13, 2008·Alzheimer Disease and Associated Disorders·Kevin DuffWilliam H Adams
Dec 5, 2008·Clinical Rehabilitation·Kjersti NøklebyTorgeir Bruun Wyller
Apr 28, 2009·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Paul MaruffRobert H Pietrzak
May 7, 2009·Journal of Geriatric Psychiatry and Neurology·Sarah E CookKarin J M McCoy

❮ Previous
Next ❯

Citations

Dec 18, 2015·Journal of the American Association of Nurse Practitioners·James R Hill
Mar 25, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Begoña OjedaInmaculada Failde
Jan 21, 2020·World Journal of Psychiatry·Diego Cahn-HidalgoReina Benabou

❮ Previous
Next ❯

Software Mentioned

Stroop
EncephalApp
CogStat
MOST
R
NeuroScreen
ACE
SAGE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.